We have recently described a novel recycling pathway of triglyceride-rich lipoprotein (TRL)-associated apolipoprotein (apo) E in human hepatoma cells. We now demonstrate that not only TRL-derived apoE but also lipoprotein lipase (LPL) is efficiently recycled in vitro and in vivo. Similar recycling kinetics of apoE and LPL in normal and low density lipoprotein receptor-negative human fibroblasts also indicate that the low density lipoprotein receptor-related protein seems to be involved. Intracellular sorting mechanisms are responsible for reduced lysosomal degradation of both ligands after receptor-mediated internalization. Immediately after internalization in rat liver, TRLs are disintegrated, and apoE and LPL are found in endosomal compartments, whereas TRL-derived phospholipids accumulate in the perinuclear region of hepatocytes. Subsequently, substantial amounts of both proteins can be found in purified recycling endosomes, indicating a potential resecretion of these TRL components. Pulse-chase experiments of perfused rat livers with radiolabeled TRLs demonstrated a serum-induced release of internalized apoE and LPL into the perfusate. Analysis of the secreted proteins identified ϳ80% of the recycled TRLderived proteins in the high density lipoprotein fractions. These results provide the first evidence that recycling of TRL-derived apoE and LPL could play an important role in the modulation of lipoproteins in vivo.Triglycerides are transported mainly by two distinct classes of triglyceride-rich lipoproteins (TRLs), 1 the chylomicrons and the very low density lipoproteins (VLDLs). After assembly in the intestine, chylomicrons are transported via lymph into the bloodstream, where they are converted at the endothelial surface to remnant lipoproteins through the catalytic action of lipoprotein lipase (LPL) (for review, see Refs. 1 and 2). After lipolysis, LPL remains associated with the chylomicron remnants and, in concert with apolipoprotein (apo) E (3-5), facilitates their clearance into hepatocytes (6) via LDL receptor (LDLR) and the LDLR-related protein (LRP) (7-10). The essential role for both receptors in TRL removal in vivo has been demonstrated in gene knockout and gene transfer experiments (Refs. 11 and 12; for a recent review, see Ref. 13).Several studies have used different "model particles" to investigate the intracellular processing of TRL constituents. In contrast to the lysosomal degradation of LDL-derived apoB (14), -VLDL-derived apoE was identified in widely distributed vesicles and showed a slow protein degradation in mouse macrophages (15, 16). However, in the same cells, -VLDLderived lipids were delivered to perinuclear, lysosomal compartments (17). Delayed transport and degradation of TRL proteins were also observed in hepatoma cells (18,19). In recent studies, we have been able to demonstrate that the altered transport and retarded degradation of internalized TRLs is due to intracellular disintegration and sorting of TRL components in a peripheral cellular compartment. Whereas lipids are ...